Karen Walker
Hoofd Techniek/Wetenschap/O&O bij KYVERNA THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Karen Walker is currently the Chief Technology Officer at Kyverna Therapeutics, Inc. She is also a member of the Parenteral Drug Association, Alliance For Regenerative Medicine’s Foundation, and PDA ATMP Working Group.
Previously, she held the position of Vice President at Novartis, Inc. and Seagen Inc. Ms. Walker received her undergraduate degree from St. Olaf College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Karen Walker
| Bedrijven | Functie | Begin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 |
| Alliance For Regenerative Medicine’S Foundation | Corporate Officer/Principal | - |
| Parenteral Drug Association | Corporate Officer/Principal | - |
Eerdere bekende functies van Karen Walker
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
| SEAGEN INC. | Corporate Officer/Principal | - |
Opleiding van Karen Walker
| St. Olaf College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KYVERNA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
| Alliance For Regenerative Medicine’S Foundation | |
| Parenteral Drug Association |
